UK Markets closed

Veritiv Corporation (VRTV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
144.95+5.81 (+4.18%)
At close: 04:00PM EDT
144.95 +0.02 (+0.01%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.27
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3158.99
52-week low 355.11
50-day moving average 3138.04
200-day moving average 3115.03

Share statistics

Avg vol (3-month) 3105k
Avg vol (10-day) 3119.61k
Shares outstanding 514.59M
Implied shares outstanding 6N/A
Float 810.56M
% held by insiders 13.20%
% held by institutions 192.70%
Shares short (28 Apr 2022) 4201.73k
Short ratio (28 Apr 2022) 42.04
Short % of float (28 Apr 2022) 42.35%
Short % of shares outstanding (28 Apr 2022) 41.34%
Shares short (prior month 30 Mar 2022) 4214.14k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 2.11%
Operating margin (ttm)3.36%

Management effectiveness

Return on assets (ttm)6.03%
Return on equity (ttm)23.73%

Income statement

Revenue (ttm)6.85B
Revenue per share (ttm)450.10
Quarterly revenue growth (yoy)13.50%
Gross profit (ttm)1.43B
EBITDA 271.7M
Net income avi to common (ttm)144.6M
Diluted EPS (ttm)7.24
Quarterly earnings growth (yoy)77.80%

Balance sheet

Total cash (mrq)49.3M
Total cash per share (mrq)3.36
Total debt (mrq)925.2M
Total debt/equity (mrq)145.52
Current ratio (mrq)1.92
Book value per share (mrq)38.84

Cash flow statement

Operating cash flow (ttm)154.7M
Levered free cash flow (ttm)104.42M